Cargando…

FXYD proteins and sodium pump regulatory mechanisms

The sodium/potassium-ATPase (NKA) is the enzyme that establishes gradients of sodium and potassium across the plasma membrane. NKA activity is tightly regulated for different physiological contexts through interactions with single-span transmembrane peptides, the FXYD proteins. This diverse family o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yap, John Q., Seflova, Jaroslava, Sweazey, Ryan, Artigas, Pablo, Robia, Seth L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953255/ https://www.ncbi.nlm.nih.gov/pubmed/33688925 http://dx.doi.org/10.1085/jgp.202012633

Ejemplares similares

Fluorescence lifetime imaging microscopy reveals sodium pump dimers in live cells
por: Seflova, Jaroslava, et al.
Publicado: (2022)

FXYD protein isoforms differentially modulate human Na/K pump function
por: Meyer, Dylan J., et al.
Publicado: (2020)

Inhibitory and stimulatory micropeptides preferentially bind to different conformations of the cardiac calcium pump
por: Cleary, Sean R., et al.
Publicado: (2022)

What FXYDs fix
por: Habeck, Michael, et al.
Publicado: (2021)

Displacement of Native FXYD Protein From Na(+)/K(+)-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity
por: Liu, Chia-Chi, et al.
Publicado: (2022)

Expression and Significance of FXYD-3 Protein in Gastric Adenocarcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2010)

Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma
por: Wang, Li-Juan, et al.
Publicado: (2018)

Paradoxical activation of the sodium chloride cotransporter (NCC) without hypertension in kidney deficient in a regulatory subunit of Na,K‐ATPase, FXYD2
por: Arystarkhova, Elena, et al.
Publicado: (2014)

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport
por: Arystarkhova, Elena, et al.
Publicado: (2017)

FXYD6 is a new biomarker of cholangiocarcinoma
por: CHEN, XIONGFEI, et al.
Publicado: (2014)

Sodium Flux Ratio in Na/K Pump-Channels Opened by Palytoxin
por: Rakowski, R.F., et al.
Publicado: (2007)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
por: Zhang, ZhongFa, et al.
Publicado: (2011)

Expression and clinical significance of FXYD3 in endometrial cancer
por: LI, YIFEI, et al.
Publicado: (2014)

Renal Mg handling, FXYD2 and the central role of the Na,K‐ATPase
por: Mayan, Haim, et al.
Publicado: (2018)

Beneficial Renal and Pancreatic Phenotypes in a Mouse Deficient in FXYD2 Regulatory Subunit of Na,K-ATPase
por: Arystarkhova, Elena
Publicado: (2016)

Intestinal FXYD12 and sodium-potassium ATPase: A comparative study on two euryhaline medakas in response to salinity changes
por: Yang, Wen-Kai, et al.
Publicado: (2018)

Regulation of the cardiac sodium pump
por: Fuller, W., et al.
Publicado: (2012)

FXYD-3 expression in relation to local recurrence of rectal cancer
por: Loftas, Per, et al.
Publicado: (2016)

FXYD5: Na(+)/K(+)-ATPase Regulator in Health and Disease
por: Lubarski Gotliv, Irina
Publicado: (2016)

FXYD6 promotes thermal nociception by regulating TRPV1
por: Luo, Hao, et al.
Publicado: (2021)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Effect of differentiation, de novo innervation, and electrical pulse stimulation on mRNA and protein expression of Na(+),K(+)-ATPase, FXYD1, and FXYD5 in cultured human skeletal muscle cells
por: Jan, Vid, et al.
Publicado: (2021)

Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhang, Zedan, et al.
Publicado: (2022)

Structure and function of H(+)/K(+) pump mutants reveal Na(+)/K(+) pump mechanisms
por: Young, Victoria C., et al.
Publicado: (2022)

FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury
por: Brazee, Patricia L., et al.
Publicado: (2017)

The Ile191Val is a partial loss-of-function variant of the TAS1R2 sweet-taste receptor and is associated with reduced glucose excursions in humans
por: Serrano, Joan, et al.
Publicado: (2021)

FXYD6: a novel therapeutic target toward hepatocellular carcinoma
por: Gao, Qian, et al.
Publicado: (2014)

Expression mode and prognostic value of FXYD family members in colon cancer
por: Jin, Ming, et al.
Publicado: (2021)

Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues
por: Cuomo, Mariella, et al.
Publicado: (2022)

Flavonolignans As a Novel Class of Sodium Pump Inhibitors
por: Kubala, Martin, et al.
Publicado: (2016)

Large Diameter of Palytoxin-induced Na/K Pump Channels and Modulation of Palytoxin Interaction by Na/K Pump Ligands
por: Artigas, Pablo, et al.
Publicado: (2004)

Molecular mechanism of light-driven sodium pumping
por: Kovalev, Kirill, et al.
Publicado: (2020)

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2013)

2-Color Calcium Pump Reveals Closure of the Cytoplasmic Headpiece with Calcium Binding
por: Hou, Zhanjia, et al.
Publicado: (2012)

A Structural Mechanism for Calcium Transporter Headpiece Closure
por: Smolin, Nikolai, et al.
Publicado: (2014)

Structure and mechanisms of sodium-pumping KR2 rhodopsin
por: Kovalev, Kirill, et al.
Publicado: (2019)

On the effect of hyperaldosteronism-inducing mutations in Na/K pumps
por: Meyer, Dylan J., et al.
Publicado: (2017)

Identification of cisplatin-binding sites on the large cytoplasmic loop of the Na(+)/K(+)-ATPase
por: Šeflová, Jaroslava, et al.
Publicado: (2018)

Is the Second Sodium Pump Electrogenic?
por: Thomas, L. E., et al.
Publicado: (2013)

The second sodium pump: from the function to the gene
por: Rocafull, Miguel A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mqucjmpnj8vvsg6a3s52ah06lg